-

The Worldwide Healthcare Fraud Analytics Industry is Expected to Reach $13.6 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Healthcare Fraud Analytics Market Research Report by Solution Type, Delivery Model, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Healthcare Fraud Analytics Market size was estimated at USD 4,865.98 million in 2021, USD 5,769.60 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.82% to reach USD 13,696.75 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Fraud Analytics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Healthcare Fraud Analytics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Fraud Analytics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Fraud Analytics Market?

4. What is the competitive strategic window for opportunities in the Global Healthcare Fraud Analytics Market?

5. What are the technology trends and regulatory frameworks in the Global Healthcare Fraud Analytics Market?

6. What is the market share of the leading vendors in the Global Healthcare Fraud Analytics Market?

7. What modes and strategic moves are considered suitable for entering the Global Healthcare Fraud Analytics Market?

Market Dynamics

Drivers

  • Increasing number of fraudulent activities in the healthcare sector
  • Growing adoption of health insurance plans across the globe
  • Surge in discipline to keep trace of fraud & abuse in health care domain

Restraints

  • High cost of healthcare fraud analytics services

Opportunities

  • Introduction of healthcare BPO and fraud identity management software
  • Proliferation of social media platforms and their impact on healthcare
  • Integration of AI in healthcare services and solutions

Challenges

  • Lack of skilled and experienced professionals

Companies Mentioned

  • CGI Group
  • CGI INC.
  • Change Healthcare Inc
  • Coviti, Inc.
  • DCX Technology
  • EXLSERVICE HOLDINGS, INC.
  • Fair Isaac Corporation
  • FRAUDLENS, INC.
  • FRISS Fraudebestrijding B.V.
  • HCL TECHNOLOGIES LIMITED
  • HMS HOLDINGS CORP.
  • International Business Machines Corporation
  • NORTHROP GRUMMAN CORPORATION
  • Optum, Inc.
  • QLARANT, INC.
  • SAS Institute, Inc.
  • SCIOInspire, Corp.
  • SHARECARE, INC.
  • Verscend Technologies, Inc.
  • WIPRO LIMITED

For more information about this report visit https://www.researchandmarkets.com/r/y7rd2v

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom